Literature DB >> 26272136

Establishment and Characterization of an In Vitro Model of Fas-Mediated Hepatocyte Cell Death.

Mathieu Vinken1, Michaël Maes, Sara Crespo Yanguas, Joost Willebrords, Tamara Vanhaecke, Vera Rogiers.   

Abstract

Fas-mediated apoptosis underlies a plethora of liver pathologies and toxicities. As a consequence, this process is a major research topic in the field of experimental and clinical hepatology. The present chapter describes the setup of an in vitro model of hepatocellular apoptotic cell death. In essence, this system consists of freshly isolated hepatocytes cultured in a monolayer configuration, which are exposed to a combination of Fas ligand and cycloheximide. This in vitro model has been characterized by using a set of well-acknowledged cell death markers. This experimental system allows the study of the entire course of Fas-mediated hepatocellular cell death, going from early apoptosis to secondary necrosis, and hence can serve a broad range of in vitro pharmaco-toxicological purposes.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26272136      PMCID: PMC4579547          DOI: 10.1007/978-1-4939-2074-7_6

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  29 in total

1.  The effects of cell density, attachment substratum and dexamethasone on spontaneous apoptosis of rat hepatocytes in primary culture.

Authors:  L Qiao; G C Farrell
Journal:  In Vitro Cell Dev Biol Anim       Date:  1999 Jul-Aug       Impact factor: 2.416

2.  Anti-Fas IgG1 antibodies recognizing the same epitope of Fas/APO-1 mediate different biological effects in vitro.

Authors:  B Fadeel; C J Thorpe; S Yonehara; F Chiodi
Journal:  Int Immunol       Date:  1997-02       Impact factor: 4.823

Review 3.  Liver apoptosis.

Authors:  G Feldmann
Journal:  J Hepatol       Date:  1997       Impact factor: 25.083

4.  Fas/APO-1(CD95)-induced apoptosis of primary hepatocytes is inhibited by cAMP.

Authors:  K E Fladmark; B T Gjertsen; S O Døskeland; O K Vintermyr
Journal:  Biochem Biophys Res Commun       Date:  1997-03-06       Impact factor: 3.575

5.  Agonist antibody and Fas ligand mediate different sensitivity to death in the signaling pathways of Fas and cytoplasmic mutants.

Authors:  A R Thilenius; K Braun; J H Russell
Journal:  Eur J Immunol       Date:  1997-05       Impact factor: 5.532

Review 6.  Apoptosis and necrosis in toxicology: a continuum or distinct modes of cell death?

Authors:  M Raffray; G M Cohen
Journal:  Pharmacol Ther       Date:  1997-09       Impact factor: 12.310

7.  Hypothermia inhibits Fas-mediated apoptosis of primary mouse hepatocytes in culture.

Authors:  Tao Fu; Andres T Blei; Noriaki Takamura; Tesu Lin; Danqing Guo; Honglin Li; Maurice R O'Gorman; Humberto E Soriano
Journal:  Cell Transplant       Date:  2004       Impact factor: 4.064

8.  Lethal effect of the anti-Fas antibody in mice.

Authors:  J Ogasawara; R Watanabe-Fukunaga; M Adachi; A Matsuzawa; T Kasugai; Y Kitamura; N Itoh; T Suda; S Nagata
Journal:  Nature       Date:  1993-08-26       Impact factor: 49.962

9.  Effect of the histone deacetylase inhibitor trichostatin A on spontaneous apoptosis in various types of adult rat hepatocyte cultures.

Authors:  Tamara Vanhaecke; Tom Henkens; George E N Kass; Vera Rogiers
Journal:  Biochem Pharmacol       Date:  2004-08-15       Impact factor: 5.858

10.  Cutting edge: SDS-stable Fas microaggregates: an early event of Fas activation occurring with agonistic anti-Fas antibody but not with Fas ligand.

Authors:  Patrick Legembre; Marie Beneteau; Sophie Daburon; Jean-François Moreau; Jean-Luc Taupin
Journal:  J Immunol       Date:  2003-12-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.